David Altshuler
2016
In 2016, David Altshuler earned a total compensation of $4.8M as EVP & Chief Scientific Officer at Vertex Pharmaceuticals, a 61% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $500,250 |
|---|---|
| Option Awards | $1,087,620 |
| Salary | $561,442 |
| Stock Awards | $2,625,152 |
| Other | $12,885 |
| Total | $4,787,349 |
Altshuler received $2.6M in stock awards, accounting for 55% of the total pay in 2016.
Altshuler also received $500.3K in non-equity incentive plan, $1.1M in option awards, $561.4K in salary and $12.9K in other compensation.
Rankings
In 2016, David Altshuler's compensation ranked 1,719th out of 14,075 executives tracked by ExecPay. In other words, Altshuler earned more than 87.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,719 out of 14,075 | 88th |
Division Manufacturing | 586 out of 5,488 | 89th |
Major group Chemicals And Allied Products | 163 out of 1,900 | 91st |
Industry group Drugs | 112 out of 1,543 | 93rd |
Industry Pharmaceutical Preparations | 88 out of 1,173 | 93rd |
Source: SEC filing on April 28, 2017.
Altshuler's colleagues
We found five more compensation records of executives who worked with David Altshuler at Vertex Pharmaceuticals in 2016.
2016
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2016
Michael Parini
Vertex Pharmaceuticals
EVP & Chief Legal and Administrative Officer
2016
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2016
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2016
Amit Sachdev
Vertex Pharmaceuticals